Creation of an mHealth Infrastructure to Support the Development and Delivery of mHealth Interventions: Protocol for Demonstration Projects Addressing Smoking Cessation in Cancer Care
Clinical Snapshot
PICO Framework
| P — Population | Cancer patients who smoke, researchers developing mHealth interventions |
| I — Intervention | mHealth Florida infrastructure (mFLi) platform for app development and delivery |
| C — Comparator | Traditional mHealth development approaches (implied) |
| O — Outcomes | Platform functionality, utility, adaptability; smoking cessation outcomes in demonstration projects |
Bottom Line
This protocol describes development of a comprehensive mHealth infrastructure platform designed to streamline mobile app development for behavioural interventions, with initial demonstration projects focusing on smoking cessation in cancer patients. While the technical approach appears robust with multidisciplinary expertise, the protocol lacks sufficient detail on clinical methodology, outcome measures, and statistical analysis plans. The platform's modular design and machine learning capabilities are promising features that could accelerate mHealth research. However, as a US-based infrastructure, direct applicability to Australian healthcare settings may be limited. The ongoing demonstration studies will be crucial for evaluating both technical functionality and clinical effectiveness. Clinicians should await publication of results before drawing conclusions about the platform's clinical utility.
Key Findings
P Value: Not yet available
Effect Size: Not yet available - study ongoing
Primary Outcome: Platform functionality and smoking cessation outcomes (pending)
Nnt Or Sensitivity: Not yet determined
Confidence Interval: Not yet available
Clinical Application
Requires significant technical infrastructure and ongoing maintenance Limited direct applicability due to different healthcare systems, though principles may inform Australian mHealth development initiatives Cancer patients who smoke and have smartphone access
Abstract
BACKGROUND: Cancer remains a leading cause of morbidity worldwide. To reduce this burden, scalable, effective approaches are needed to address modifiable risk factors for cancer and support behavioral self-management. With smartphone ownership now nearly ubiquitous, mobile health (mHealth) interventions offer a powerful means to extend the reach, accessibility, and sustainability of evidence-based treatments for a variety of modifiable risk factors (eg, excessive alcohol use, physical inactivity, poor diet, and smoking). Moreover, the flexibility of mHealth platforms enables efficient delivery of novel interventions, supports innovative study designs, and facilitates real-time data collection to advance public health research. OBJECTIVE: Despite the great potential of mHealth interventions, developing high-quality mHealth tools is complex, time-consuming, and resource-intensive. To address these challenges, we are developing a coordinated, accessible, research-grade infrastructure for mHealth app development, testing, and dissemination. METHODS: The mHealth Florida infrastructure (mFLi) will provide a comprehensive, low-code software platform that enables researchers to build apps compatible with major mobile operating systems, namely, Apple iOS and Google Android. Through a modular interface, users will select from a menu of prebuilt features to tailor functionality to specific study needs. The platform will include 3 integrated environments (development, testing, and production), allowing researchers to prototype, evaluate, and deploy mHealth interventions. This infrastructure will be developed and maintained by a multidisciplinary team, ensuring that the platform is technically robust and usable and adheres to institutional and regulatory standards. To demonstrate the platform's functionality, utility, and adaptability, a multisite study comprising three initial projects focused on smoking cessation among patients with cancer is being conducted: (1) participant screening and enrollment, (2) randomization and treatment delivery, and (3) data processing using machine learning methods with on-device and cloud-based approaches. RESULTS: This study was funded in May 2023, and ethics approval was obtained from all involved sites' institutional review boards between February 2024 and October 2025. Recruitment began in March 2025 and enrollment is ongoing. As of January 2026, 41% (37/90) of the target sample have been enrolled and 21% (19/90) have completed their 6-month assessment. Data collection will be completed once the final participant completes their 6-month assessment (expected May 2027), with analyses commencing thereafter. Study findings are anticipated to be published in a peer-reviewed journal in 2027. CONCLUSIONS: Collectively, these projects will illustrate how mFLi can streamline app development, facilitate rapid translation of research into practice, and reduce barriers for researchers and developers. Ultimately, mFLi is designed to accelerate innovation in mHealth research, enhance access to behavioral interventions, and improve health outcomes among diverse populations. TRIAL REGISTRATION: ClinicalTrials.gov NCT06909357; https://clinicaltrials.gov/study/NCT06909357. INTERNATIONAL REGISTERED REPORT IDENTIFIER (IRRID): PRR1-10.2196/92288.
References
- 1.Sparrock, L. S., Vidrine, J. I., Vinci, C. E., El Naqa, I. M., Sutton, S. K., Salloum, R. G., Dallery, J., Crane, T. E., Penedo, F. J., Brockway, S. J., Jones, S. R., Hoogland, C. E., Reich, R. R., Gonzalez-Calderon, G., Simmons, V. N., & Vidrine, D. J. (2026). Creation of an mHealth Infrastructure to Support the Development and Delivery of mHealth Interventions: Protocol for Demonstration Projects Addressing Smoking Cessation in Cancer Care. JMIR Research Protocols. https://doi.org/10.2196/92288
Related Research
The American journal of pathology
An Integrated Machine Learning and Genomic Framework for Precise Detection of Gastric Cancer
3 Aug 2026
Current opinion in chemical biology
Prediction of protein-protein interactions and co-complex models with deep learning
3 Aug 2026
European journal of radiology
A CT-based deep learning model to differentiate between benign and malignant adrenal lesions
3 Aug 2026
This content is for educational purposes for healthcare professionals only and does not constitute clinical advice. Clinical decisions should be based on individual patient assessment, current guidelines, and appropriate specialist consultation. Editorial Standards · Privacy Policy · Terms of Service